Control of Healthcare-Associated Carbapenem-Resistant <i>Acinetobacter baumannii</i> by Enhancement of Infection Control Measures

Antimicrobial stewardship and infection control measures are equally important in the control of antimicrobial-resistant organisms. We conducted a retrospective analysis of the incidence rate of hospital-onset carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) infection (per 1000...

Full description

Bibliographic Details
Published in:	Antibiotics
Main Authors:	Shuk-Ching Wong, Pui-Hing Chau, Simon Yung-Chun So, Germaine Kit-Ming Lam, Veronica Wing-Man Chan, Lithia Lai-Ha Yuen, Christine Ho-Yan Au Yeung, Jonathan Hon-Kwan Chen, Pak-Leung Ho, Kwok-Yung Yuen, Vincent Chi-Chung Cheng
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Subjects:	carbapenem-resistant <i>Acinetobacter baumannii</i> multidrug-resistant <i>Acinetobacter baumannii</i> carbapenem-resistant Enterobacterales healthcare-associated infection antimicrobial consumption infection control
Online Access:	https://www.mdpi.com/2079-6382/11/8/1076

Similar Items

Gastrointestinal Colonization of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: What Is the Implication for Infection Control?
by: Shuk-Ching Wong, et al.
Published: (2022-09-01)

Comparative Analysis of Clinical Characteristics and Antimicrobial Resistance Between <i>Acinetobacter baumannii</i> and Other <i>Acinetobacter</i> Species
by: Si-Ho Kim, et al.
Published: (2025-01-01)

The Multifaceted Landscape of Healthcare-Associated Infections Caused by Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Alessandro Russo, et al.
Published: (2025-04-01)

Genomic Analysis of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolated from Bloodstream Infections in South Korea
by: Wook Jong Jeon, et al.
Published: (2024-11-01)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01)

Challenges Facing Two Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants
by: Montserrat Rodríguez-Aguirregabiria, et al.
Published: (2024-08-01)

<i>Acinetobacter baumannii</i> Bloodstream Infections: A Nationwide Study in Israel
by: Amir Nutman, et al.
Published: (2023-08-01)

Prevalence of Carbapenem-Resistant Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa in a Tertiary Care Hospital in Eastern India: A Pilot Study
by: Gaurav Verma, et al.
Published: (2023-12-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Tsung-Ying Yang, et al.
Published: (2021-08-01)

The Impact of Antimicrobial Stewardship and Infection Control Interventions on <i>Acinetobacter baumannii</i> Resistance Rates in the ICU of a Tertiary Care Center in Lebanon
by: Nesrine A. Rizk, et al.
Published: (2022-07-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021-08-01)

Comparison of Hypervirulent and Non-Hypervirulent Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolated from Bloodstream Infections: Mortality, Potential Virulence Factors, and Combination Therapy In Vitro
by: Likang Yao, et al.
Published: (2024-08-01)

Prevalence and Antibiogram Pattern of <i>Acinetobacter baumannii</i> from 2013 to 2023 in a Tertiary Care Hospital in the Western Region of Saudi Arabia
by: Ohood Alharbi, et al.
Published: (2025-03-01)

Clinical Efficacy of Sitafloxacin–Colistin–Meropenem and Colistin–Meropenem in Patients with Carbapenem-Resistant and Multidrug-Resistant <i>Acinetobacter baumannii</i> Hospital-Acquired Pneumonia (HAP)/Ventilator-Associated Pneumonia (VAP) in One Super-Tertiary Hospital in Bangkok, Thailand: A Randomized Controlled Trial
by: Manasawee Wantanatavatod, et al.
Published: (2024-01-01)

Complex Infection-Control Measures with Disinfectant Switch Help the Successful Early Control of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Outbreak in Intensive Care Unit
by: Jozsef Kelemen, et al.
Published: (2024-09-01)

Isolation and Characterization of Novel Bacteriophages to Target Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Yoon-Jung Choi, et al.
Published: (2024-06-01)

Phenotypic and molecular characterisations of carbapenem-resistant Acinetobacter baumannii strains isolated in Madagascar
by: Pierrette Landrie Simo Tchuinte, et al.
Published: (2019-02-01)

Preoptimized phage cocktail for use in aerosols against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii: A 3-year prospective intervention study
by: Li-Kuang Chen, et al.
Published: (2022-05-01)

Moving toward Extensively Drug-Resistant: Four-Year Antimicrobial Resistance Trends of <i>Acinetobacter baumannii</i> from the Largest Department of Internal Medicine in Slovakia
by: Yashar Jalali, et al.
Published: (2023-07-01)

Molecular Epidemiology of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Strains Isolated at the German Military Field Laboratory in Mazar-e Sharif, Afghanistan
by: Paul G. Higgins, et al.
Published: (2021-10-01)

Molecular Characterization of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolated from the Intensive Care Unit in a Tertiary Teaching Hospital in Malaysia
by: Jia Jie Woon, et al.
Published: (2021-11-01)

High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and <i>Acinetobacter baumannii</i>
by: Massimiliano De Angelis, et al.
Published: (2022-02-01)

Exploring the clinical outcomes and molecular characteristics of Acinetobacter baumannii bloodstream infections: a study of sequence types, capsular types, and drug resistance in China
by: Jiao Chen, et al.
Published: (2025-02-01)

Corrigendum: Exploring the clinical outcomes and molecular characteristics of Acinetobacter baumannii bloodstream infections: a study of sequence types, capsular types, and drug resistance in China
by: Jiao Chen, et al.
Published: (2025-03-01)

Antimicrobial Susceptibility Profiles of <i>Acinetobacter baumannii</i> Strains, Isolated from Clinical Cases of Companion Animals in Greece
by: Marios Lysitsas, et al.
Published: (2023-10-01)

Rifampicin Enhanced Carbapenem Activity with Improved Antibacterial Effects and Eradicates Established <i>Acinetobacter baumannii</i> Biofilms
by: Lois Chinwe Nwabor, et al.
Published: (2023-03-01)

Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>: A Propensity Score-Matched Cohort Study
by: Lei Zha, et al.
Published: (2023-01-01)

New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria
by: Elisabete Machado, et al.
Published: (2025-10-01)

Risk Factors for Development and Mortality of Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
by: Li L, et al.
Published: (2024-12-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates in a Hollow-Fibre Infection Model
by: Sazlyna Mohd Sazlly Lim, et al.
Published: (2022-11-01)

Prevalence of infections with antibiotic-resistant Acinetobacter baumannii in different clinical samples from hospitals in Erbil
by: Sakar B. Smai, et al.
Published: (2020-06-01)

The Characterisation of Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> in a Teaching Hospital in Malaysia
by: Min Yi Lau, et al.
Published: (2024-11-01)

A Prevalence of infections with antibiotic-resistant Acinetobacter baumannii in different clinical samples from hospitals in Erbil
by: Sakar B. Smai, et al.
Published: (2020-06-01)

Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of <i>Acinetobacter baumannii</i> Clinical Isolates
by: Clara Ballesté-Delpierre, et al.
Published: (2022-01-01)

Nosocomial carbapenem-drug resistant Acinetobacter baumannii, related factors and clinical outcomes in Northeast Iran
by: Yasaman Alidoosti, et al.
Published: (2024-10-01)

Multicenter Study of the Risk Factors and Outcomes of Bloodstream Infections Caused by Carbapenem-Non-Susceptible <i>Acinetobacter baumannii</i> in Indonesia
by: Dewi Anggraini, et al.
Published: (2022-07-01)

Detection of Clonal Relationship Between Carbapenem-resistant Acinetobacter baumannii Isolates in an University Hospital
by: Yasemin KIRIK, et al.
Published: (2021-12-01)

WGS-Based Analysis of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Vietnam and Molecular Characterization of Antimicrobial Determinants and MLST in Southeast Asia
by: Gamal Wareth, et al.
Published: (2021-05-01)